Sodium Thiosulfate to Preserve Cardiac Function in STEMI

A phase 2 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 380 participants.

Also called NCT02899364

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; triple masking; primary purpose prevention
Phase
Phase 2
Enrolled
  • 380 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT02899364
  • EudraCT 2015-001006-34
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Netherlands (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT02899364. Randomized; triple masking; primary purpose prevention. Start 2018-07-20 (actual); primary completion 2021-06-25 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Sodium Thiosulfate to Preserve Cardiac Function in STEMI
Acronym
GIPS-IV
Condition
Heart Failure
Intervention (Drug)
Sodium thiosulfate
Intervention (Drug)
Sodium chloride 0.9%
Intervention (Procedure)
primary percutaneous coronary intervention
Intervention (Other)
cardiac magnetic resonance imaging
Lead sponsor
University Medical Center Groningen (class: other)

Record details

Record id
cardio:ct-nct02899364
Content hash
cd7a3eb49ddcdafbcd72fcd15f0fec87d4725b74f24b223ebc6b77fdc7689a71